Autoantibodies against vinculin in patients with chronic inflammatory demyelinating polyneuropathy

J Neuroimmunol. 2015 Oct 15:287:9-15. doi: 10.1016/j.jneuroim.2015.07.012. Epub 2015 Jul 29.

Abstract

To identify the target molecules of chronic inflammatory demyelinating polyneuropathy (CIDP), we used proteomic-based approach in the extracted proteins from porcine cauda equina. Two of 31 CIDP patients had markedly elevated serum autoantibodies against vinculin, a cell adhesion protein. Both of the patients with anti-vinculin antibodies had similar clinical manifestation, which are compatible with those of "typical" CIDP. Immunocytochemistry showed that vinculin was stained at the myelin sheath of the sciatic nerves by serum samples. Our results suggest that vinculin is a possible immunological target molecule in a subpopulation of typical CIDP patients.

Keywords: Autoantibody; Chronic inflammatory demyelinating polyneuropathy; Epitope; Vinculin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Autoantibodies / blood*
  • Case-Control Studies
  • Female
  • Humans
  • Male
  • Multiple Sclerosis / blood
  • Multiple Sclerosis / immunology
  • Myasthenia Gravis / blood
  • Myasthenia Gravis / immunology
  • Myelin Sheath / metabolism
  • Neuromyelitis Optica / blood
  • Neuromyelitis Optica / immunology
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / blood*
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / immunology*
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / pathology
  • Proteomics
  • Schwann Cells / metabolism
  • Swine
  • Vinculin / immunology*

Substances

  • Autoantibodies
  • Vinculin